This website uses cookies to help us understand the way visitors use our website. We can't identify you with them and we don't share the data with anyone else. If you click Reject we will set a single cookie to remember your preference. Find out more in our privacy policy.

Test page for company engagement form

For more information please see https://www.gov.uk/government/collections/uk-sanctions-regimes-under-the-sanctions-act

This may be a parent Company or person with significant control.



















Summary of the Innovation
Please only include details of one innovation on this form.



Only complete this field if you selected ‘other’ in the field above
Please provide a brief description of the innovation, including its intended purpose, functionality (how it works), clinical setting/ pathway, and the opportunity (size of intended patient group)
(please select no more than four options)
Only complete this field if you selected ‘other’ in the field above

(please select no more than four options)
Only complete this field if you selected ‘Other’ in the field above


Describe any engagement you have had with key stakeholders (e.g. clinicians, patients, commissioners)
Highlight existing, similar or equivalent technologies, products or services. Outline how your innovation is different to existing technologies, products or services
It is important that innovations are acceptable (informed by what patients want) and accessible (usable) to the people who will use or be affected by them. Assurance that innovations are informed by patient views, improves safety, health outcome and saves money. In this section, briefly describe if and how patients, carers, and the public have been involved in your innovation, including any feedback patients have about your innovation.
Read more about what health inequalities are here. Find out the current NHS England priority areas to tackle health inequalities for adults and children.
Does your innovation have a direct or indirect impact on NHS net zero/ environmental sustainability? Direct – refers to when an innovation is created solely to reduce carbon emissions/ provide environmental benefits – e.g. reusable product/ better use of materials and natural resources in creation of product/ reduce fossil fuel usage. Indirect refers to when an innovation is created for healthcare use but net zero/ environmental benefits are a secondary benefit – e.g. Digital platform to manage patient care – that can help reduce travel/ make care more efficient and effective.





– Initial idea
– Intellectual property protected
– User testing
– Proof of concept tested
– Early prototype
– Working prototype/ pathway developed
– Clinical evidence (or equivalent)
– Pilot/ real-world evaluation
– Regulatory status
– Adoption & spread
– Other (NICE guidance, case studies, inclusion on any accelerator programmes etc.)

Only complete this field if you selected ‘Other’ in the field above



Only complete this field if you selected ‘other’ in the field above








For more information about our privacy practices please visit our privacy policy.